How many people a hazardous substance makes ill sounds like a medical question. For asbestos, it is to a large extent a legal one. Whether an illness is counted, insured and compensated as an asbestos consequence depends not on the diagnosis alone, but on whether the case fits a legal category: the occupational disease (Berufskrankheit). This post shows that this category has two nested gaps. The first lies within the occupational system itself: Austria recognises only part of the occupationally caused mesotheliomas (Section 3). The second is more fundamental: anyone who inhaled the asbestos not at work but at home or in the environment falls outside the concept of occupational disease from the start (Section 4). France, which has closed both gaps, serves as the comparison (Section 5). Austrian law is in the foreground; the German and French systems serve as contrast. Every figure is backed by its primary source; the full citations are at the end. The concrete Austrian findings and the case curve are covered by the mesothelioma map.
Who counts as a victim is decided by a legal category
Mesothelioma, the tumour of the pleura and peritoneum, is the signature disease of asbestos: hardly any common cancer is so tightly bound to a single cause. In Austria the number of registered cases is still rising, decades after the 1990 use ban, because between exposure and disease typically more than thirty years elapse. The mesothelioma map places this curve in context.
The figure that enters statistics and compensation systems, however, is not the number of the ill, but the number of recognised cases. And recognition is a legal act, not a medical finding. Who decides, by what criteria, with what result: this shapes the publicly visible picture of an asbestos epidemic more than the pure epidemiology would suggest. The thesis of this post is that the resulting undercount is not accidental but structural: it follows from the construction of the category itself.
How Austria recognises occupational diseases
The Austrian system is a list system. Under Section 177(1) of the General Social Insurance Act (ASVG), a disease counts as an occupational disease only if it is named in Annex 1 to the ASVG and occurs under the conditions described there. The individual case is decided by the Austrian Workers' Compensation Board (AUVA) as the competent accident-insurance institution. For unlisted diseases there is a narrow general clause (Section 177(2) ASVG): recognition in an individual case, but only given secured scientific findings and with the consent of the competent federal minister.
Asbestos is broadly represented in this list. Since the recast of Annex 1, which took effect on 1 March 2024, asbestos-caused diseases occupy five positions: asbestosis (item 1.3), mesothelioma as "malignant neoplasms of the pleura, pericardium and peritoneum caused by asbestos" (7.1.1), lung cancer caused by asbestos (7.1.2), laryngeal cancer caused by asbestos (7.5.2) and, new since 2024, ovarian cancer after asbestos exposure (7.7.1). All apply to "all enterprises", that is, without industry restriction (Annex 1 to the ASVG, current version). The route into the statistics begins with a physician's report: Section 363(2) ASVG obliges doctors to report a founded suspicion of an occupational disease to the institution, with a short deadline and, in case of omission, under threat of a fine.
For a case to be recognised, the disease must not only be reported but also traced back to the occupational asbestos exposure. Here lies an often overlooked asymmetry between the disease patterns, which the fold-out below unpacks.
For experts (or the expert-curious): the Austrian recognition mechanics and the dose asymmetry
The statutory text of Annex 1 names no quantitative threshold for any of the malignant asbestos consequences: both mesothelioma (7.1.1) and lung cancer (7.1.2) are defined simply as disease "caused by asbestos". The threshold arises only in application. In Austrian occupational-medicine practice, a cumulative exposure of about 20 fibre-years, alternatively the demonstration of pleural plaques or histologically confirmed asbestosis, functions as the recognition criterion for asbestos-related lung cancer (Machan et al. 2020). This mirrors the logic of the German occupational disease 4104, but it is Austrian practice, not Austrian law. What a fibre-year is, is explained in the fold-out of the fundamentals post.
For mesothelioma no such dose criterion exists, neither in law nor in practice. That is consistent: unlike lung cancer, mesothelioma is regarded as not clearly dose-dependent, it can occur after comparatively low exposure, and it has hardly any cause other than asbestos. It is precisely this circumstance that makes the low recognition rate (Section 3) call for explanation: for mesothelioma the causation is easier to establish than for any other asbestos-caused cancer.
A note on nomenclature: until the 2024 recast, Annex 1 grouped the classic asbestos diseases under a single position, usually cited in the literature as "occupational disease No. 27". This numbering is obsolete and no longer describes the law in force. Nor are the German numbers 4103 to 4105 Austrian law; they appear here only as a comparison.
Gap 1: the occupational under-recognition
How large the gap between disease and recognition is has been quantified by an Austrian study. Hochgatterer et al. (2020) compared the mesotheliomas recorded in the cancer registry of Statistics Austria with the cases that the AUVA recognised as an occupational disease in the same period. For the years 2004 to 2016, 1,356 registered mesotheliomas (ICD-10 C45, first diagnoses) stand against 543 recognised occupational diseases. That is around 40 percent (Hochgatterer et al. 2020).
Two clarifications matter here, because they often slip. First, this rate is a recognition rate, not a measured reporting behaviour: it compares registry cases with recognised cases, not reported with recognised. That a poor physician reporting behaviour lies chiefly behind the low rate is the authors' reasoned assumption, not a measured quantity (Hochgatterer et al. 2020). Second, the gap does not lie in cancer registration itself: the Austrian cancer registry is regarded as nearly complete, with a completeness of about 94 percent in a methodological assessment (Hackl and Waldhör 2013). This figure concerns registry completeness in general, not mesothelioma in particular; but it shows that the loss does not arise in counting the ill, but in recognising the cause. Within Austria, recognition also varied markedly by region, with noticeably worse shares in Lower Austria and Tyrol than in Upper Austria (Hochgatterer et al. 2020).
That it can be otherwise is shown by the comparison the same study makes. For Germany, the authors calculate a rate of around 65 percent for the year 2016, by setting the mesotheliomas recognised by the accident insurers against the cases newly diagnosed in the same year (Hochgatterer et al. 2020). This figure is a cross-section of a single year, not a value tracked across cohorts, and it fluctuates: current figures of the German Statutory Accident Insurance report, for occupational disease 4105 (mesothelioma caused by asbestos), 610 recognised cases in 2022 and 651 in 2023 (DGUV, occupational-disease statistics). The point is not the second decimal, but the direction: Germany recognises a markedly larger share of its mesotheliomas as an occupational disease than Austria. How two occupation-centred systems and one universal system differ is shown by the fold-out.
For experts (or the expert-curious): three compensation systems compared, AUVA, DGUV, FIVA
Austria and Germany share the same basic architecture: an occupation-centred system. In Austria, Section 177 ASVG binds recognition to the insured occupational activity; in Germany, Section 9(1) of the Seventh Social Code (SGB VII) defines occupational diseases as diseases that insured persons suffer "as a consequence of an activity establishing insurance cover under Sections 2, 3 or 6". In both countries the basis of claim is the work. Whoever was not exposed as an employee has no place in this system, regardless of how unambiguously the disease is asbestos-caused.
France chose a different route in 2000. The Fund for the Compensation of Asbestos Victims (FIVA), established by Article 53 of Law No. 2000-1257, compensates, under the principle of full reparation (réparation intégrale), all asbestos victims, expressly including those with non-occupational, that is environmental or domestic, exposure (loi n° 2000-1257, art. 53, current version). The difference is not gradual but categorical: FIVA asks about the disease and its asbestos cause, not about the employment relationship.
A numerical comparison of the AT and DE recognition rates nevertheless remains delicate, because it depends on the reference quantity: registered against recognised cases over a period (the Austrian 40 percent, 2004 to 2016) measures something different from recognised against newly diagnosed cases in one year (the German 65 percent, 2016). Both figures come from the same study (Hochgatterer et al. 2020) and are disclosed there methodologically; as a rough indication of direction they hold, but they should not be over-interpreted as a precise rate.
Gap 2: the non-occupational blind spot
The first gap is a rate: of those occupationally ill, a portion is not recognised. The second gap is more fundamental, because it concerns a whole group of the ill who are not envisaged in the occupational system at all. Whoever inhaled asbestos fibres not at the workplace but at home or in the environment cannot have a mesothelioma recognised as an occupational disease, because by definition the disease is not occupational. For these people, no corresponding recognition and compensation route exists in Austria.
Yet non-occupational exposure is not a marginal phenomenon but a documented cause. Domestic or take-home exposure, in which fibres are carried into the home on work clothing, raises the risk measurably: in a large British case-control study, the mesothelioma risk among relatives of asbestos-exposed workers was approximately doubled (Rake et al. 2009). Purely environmental exposure is also documented: in California, residential proximity to naturally occurring asbestos was independently and dose-responsively associated with an increased mesothelioma risk (Pan et al. 2005). How large this non-occupational share is, and why it affects women more, is covered by the fold-out.
It is precisely into this category that the current Austrian situation around asbestos-containing rock in public space falls: affected people who may be exposed via gravel, paths or roads are not exposed occupationally. The concrete case and its status are documented on the Burgenland page.
For experts (or the expert-curious): the epidemiology of non-occupational mesotheliomas
Non-occupational exposure divides into two documented routes. The first is paraoccupational or domestic: fibres reach the household via work clothing, the washing of laundry, or living with exposed persons. A review of the international literature speaks here of solid evidence for an increased mesothelioma risk from paraoccupational exposure alone (Goldberg and Luce 2009). In a case series of 421 pleural mesotheliomas from the Italian shipyard region of Trieste-Monfalcone, women with a history of domestic asbestos exposure formed a distinct group (Bianchi et al. 1997). The second route is environmental exposure near natural deposits; classic examples are the tremolite epidemics around the Greek town of Metsovo as well as regions in Cyprus, Corsica and New Caledonia (Constantopoulos 2008; for New Caledonia, Luce et al. 2000).
Non-occupational exposure shifts the sex distribution. In the British study, 14 percent of male but 62 percent of female mesothelioma cases could not be assigned to any identified occupational or domestic asbestos exposure (Rake et al. 2009). This does not mean these cases arose without asbestos, but that in women the exposure source more often lies outside the occupational grid and is harder to demonstrate (cf. Goldberg and Luce 2009). In the Italian national surveillance, 4 percent of mesotheliomas with a known exposure source were attributed to environmental exposure (Fazzo et al. 2023). For an occupation-centred recognition system, all these cases are systematically invisible.
The comparison, and what the double undercount means
France's FIVA shows that the second gap is no natural necessity, but a design decision. The fund compensates all asbestos victims regardless of occupational status, and the environmental victims there are no theoretical item: in 2024, FIVA processed 327 files with occupational and 25 with environmental exposure (FIVA, Rapport d'activité 2024). A small but real minority that would simply have no place in the Austrian and German systems.
Both gaps together have a sober consequence for every figure one reads about asbestos. The number of recognised occupational diseases lies, for the first reason, below the number of the occupationally ill, and the number of the occupationally ill lies, for the second reason, below the number of all those made ill by asbestos. Whoever reads a population's burden off the volume of recognised occupational diseases is therefore measuring not the disease, but the category. This is not a reproach to any single authority, but a property of the system: it was built to insure occupational risks, not to count an epidemic in full. For an honest reading of the Austrian case numbers, as the mesothelioma map attempts, the basic rule follows to read the recognised cases as a lower bound, not as the full picture.
Sources
- Annex 1 to the ASVG (List of Occupational Diseases, Section 177 ASVG), Federal Law Gazette No. 189/1955 as amended (recast in force since 01.03.2024, BGBl. I No. 18/2024), items 1.3, 7.1.1, 7.1.2, 7.5.2, 7.7.1. RIS, consolidated federal law.
- Sections 177 and 363 ASVG, Federal Law Gazette No. 189/1955 as amended. RIS, consolidated federal law.
- Austrian Workers' Compensation Board (AUVA), information on occupational diseases. auva.at.
- Machan B, Berger U, Valic E, Rohrbach J, Kohl M (2020): Asbestnachsorge in Österreich (asbestos aftercare in Austria). ASU – Arbeitsmedizin, Sozialmedizin, Umweltmedizin. doi:10.17147/asu-2001-9979.
- Hochgatterer K, Moshammer H, Nikl M, Orsolits G, Letzel S (2020): Ärztliches Meldeverhalten von Berufskrankheiten in Österreich am Beispiel Mesotheliom. ASU – Arbeitsmedizin, Sozialmedizin, Umweltmedizin 2020;55(1):34–37. doi:10.17147/asu-2001-8316.
- Hackl M, Waldhör T (2013): Estimation of completeness of case ascertainment of Austrian cancer incidence data using the flow method. European Journal of Public Health. doi:10.1093/eurpub/cks125.
- German Statutory Accident Insurance (DGUV): occupational-disease figures, recognised occupational diseases (BK 4105). dguv.de, facts and figures.
- Section 9(1) SGB VII (Seventh Book of the Social Code), Germany.
- Loi n° 2000-1257 du 23 décembre 2000, article 53 (Fonds d'indemnisation des victimes de l'amiante), current version. Légifrance.
- FIVA (Fonds d'indemnisation des victimes de l'amiante): Rapport d'activité 2024. fiva.fr.
- Rake C et al. (2009): Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study. British Journal of Cancer 100:1175–1183. doi:10.1038/sj.bjc.6604879.
- Goldberg M, Luce D (2009): The health impact of nonoccupational exposure to asbestos: what do we know? European Journal of Cancer Prevention. doi:10.1097/CEJ.0b013e32832f9bee.
- Pan XL, Day HW, Wang W, Beckett LA, Schenker MB (2005): Residential proximity to naturally occurring asbestos and mesothelioma risk in California. American Journal of Respiratory and Critical Care Medicine 172:1019–1025. doi:10.1164/rccm.200412-1731OC.
- Fazzo L et al. (2023): Mesothelioma mortality and environmental asbestos exposure (Italy). International Journal of Environmental Research and Public Health 20:5957. doi:10.3390/ijerph20115957.
- Bianchi C et al. (1997): Latency periods in asbestos-related mesothelioma of the pleura. European Journal of Cancer Prevention 6:162–166. PMID 9237066.
- Constantopoulos SH (2008): Environmental mesothelioma associated with tremolite asbestos: lessons from the experiences of Turkey, Greece, Corsica, New Caledonia and Cyprus. Regulatory Toxicology and Pharmacology 52(1 Suppl):S110–S115. doi:10.1016/j.yrtph.2007.11.001.
- Luce D et al. (2000): Environmental exposure to tremolite and respiratory cancer in New Caledonia: a case-control study. American Journal of Epidemiology 151(3):259–265.
Questions on the topic? Free Initial Consultation.